LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Dignify Therapeutics…

Dignify Therapeutics Tech Stack

Dignify Therapeutics uses 8 technology products and services including Gravatar, JSON-LD, Priority Hints, and more. Explore Dignify Therapeutics's tech stack below.

  • Gravatar
    Audio, Video, Graphics
  • JSON-LD
    Javascript Frameworks
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics
  • MonsterInsights
    Web Platform Extensions
  • Contact Form 7
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Media & News

Dignify Therapeutics's Email Address Formats

Dignify Therapeutics uses at least 1 format(s):
Dignify Therapeutics Email FormatsExamplePercentage
FLast@dignifytherapeutics.comJDoe@dignifytherapeutics.com
50%
FLast@dignifytherapeutics.comJDoe@dignifytherapeutics.com
50%

Frequently Asked Questions

Where is Dignify Therapeutics's headquarters located?

Minus sign iconPlus sign iconDignify Therapeutics's main headquarters is located at P.O. Box 13169, 2 Davis Drive Research Triangle Park, NC 27709, US. The company has employees across 1 continents, including North America.

What is Dignify Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Dignify Therapeutics's main corporate office by phone at
+1-919-371-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dignify Therapeutics's official website and social media links?

Minus sign iconPlus sign iconDignify Therapeutics's official website is dignifytherapeutics.com and has social profiles on LinkedInCrunchbase.

What is Dignify Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconDignify Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dignify Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2025, Dignify Therapeutics has approximately 14 employees across 1 continents, including North America. Key team members include Chief Operating Officer: J. W.Chief Scientific Officer: K. T.President: E. B.. Explore Dignify Therapeutics's employee directory with LeadIQ.

What industry does Dignify Therapeutics belong to?

Minus sign iconPlus sign iconDignify Therapeutics operates in the Biotechnology Research industry.

What technology does Dignify Therapeutics use?

Minus sign iconPlus sign iconDignify Therapeutics's tech stack includes GravatarJSON-LDPriority HintsPHPGoogle AnalyticsMonsterInsightsContact Form 7Apache HTTP Server.

What is Dignify Therapeutics's email format?

Minus sign iconPlus sign iconDignify Therapeutics's email format typically follows the pattern of FLast@dignifytherapeutics.com. Find more Dignify Therapeutics email formats with LeadIQ.

How much funding has Dignify Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2025, Dignify Therapeutics has raised $1.2M in funding. The last funding round occurred on Sep 19, 2024 for $1.2M.

When was Dignify Therapeutics founded?

Minus sign iconPlus sign iconDignify Therapeutics was founded in 2013.

Dignify Therapeutics

Biotechnology ResearchUnited States11-50 Employees

Developer of novel drug therapies intended to restore voluntary control of excretory function to neurologically impaired people. The company provides effective and convenient pharmaceutical agents that trigger the voiding of bladder and bowel contents when the person wishes, enabling patients with spinal cord injury, spina bifida, and other neurological conditions to have an enhanced way of life.

Section iconCompany Overview

Headquarters
P.O. Box 13169, 2 Davis Drive Research Triangle Park, NC 27709, US
Phone number
+1-919-371-****
Website
dignifytherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1.2M

    Dignify Therapeutics has raised a total of $1.2M of funding over 8 rounds. Their latest funding round was raised on Sep 19, 2024 in the amount of $1.2M.

  • $1M$10M

    Dignify Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1.2M

    Dignify Therapeutics has raised a total of $1.2M of funding over 8 rounds. Their latest funding round was raised on Sep 19, 2024 in the amount of $1.2M.

  • $1M$10M

    Dignify Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. W.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. T.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. B.
    President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. V.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. D.
    Executive Chairman
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    T. T.
    Cofounder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. R.
    Executive Vice President Of Drug Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. R.
    Vp, Chemistry
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. A. K.
    Director Of Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. A. K.
    Director Of Operations
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.